Whole exome sequencing

Whole exome sequencing is a DNA test that reads the protein-coding parts of the genome, called the exome. In Immunobiology, it is used to find variants that may explain inherited immune disorders like primary immunodeficiencies.

What is Whole exome sequencing?

Whole exome sequencing is a method for reading the exome, the small fraction of your genome that contains the protein-coding parts of genes. In Immunobiology, that matters because many primary immunodeficiencies come from mutations that change how immune proteins are made or how they work.

Instead of sequencing every nucleotide in the genome, this technique focuses on the exons. Exons are the stretches of DNA that stay in the final mRNA after splicing, so they are the parts most directly tied to amino acid sequences in proteins. If a gene involved in B-cell signaling, complement function, or phagocyte killing has a harmful variant, exome sequencing is one of the fastest ways to spot it.

The usual workflow starts with a DNA sample, often from blood. The lab enriches the exome, sequences those regions using next-generation sequencing (NGS), and then uses software to compare the sequence to a reference genome. That comparison can reveal a genetic variant such as a missense change, nonsense mutation, frameshift, or splice-site disruption. Not every variant is harmful, so the next step is interpretation, which asks whether the change likely affects protein function and fits the patient’s immune symptoms.

This is why whole exome sequencing is so useful when routine testing does not give an answer. A student case might describe a person with repeated infections, a normal basic bloodwork pattern, and a family history that hints at an inherited immune problem. Exome sequencing can uncover a rare mutation that explains the pattern, even when the exact disorder was not obvious at the start.

One common misconception is that exome sequencing checks all DNA. It does not. It misses most noncoding regions, and it can also miss some structural changes or repeat expansions. So a negative result does not rule out a genetic immune disorder, it just means the answer was not found in the protein-coding regions that were examined.

Why Whole exome sequencing matters in IMMUNOBIOLOGY

Whole exome sequencing shows up in Immunobiology because primary immunodeficiencies are often genetic, and the disease mechanism usually comes down to a broken protein in the immune system. When you can connect a patient’s symptoms to a variant in a gene that controls antibodies, complement, lymphocyte development, or microbial killing, the diagnosis becomes much more precise.

That precision changes how you think about the disorder. Instead of grouping all frequent infections together, you can trace the defect to a specific pathway. For example, a mutation affecting a B-cell gene points you toward antibody problems, while a mutation in a phagocyte or complement gene points somewhere else in immune defense.

It also helps explain why some disorders are hard to catch with standard tests. A basic blood count might show a clue, but not the whole story. Exome sequencing can connect the phenotype, the visible immune problem, to the genotype, the DNA change behind it.

In class, this term often supports case-based questions about diagnosis, inheritance, and targeted treatment. It also reinforces a bigger idea in immunobiology: immune function depends on proteins, and proteins depend on the DNA sequence that encodes them. When that code changes, the immune response can change with it.

How Whole exome sequencing connects across the course

Exome

Whole exome sequencing targets the exome itself, so you need to know what counts as an exon and why those regions are sequenced first. The exome is smaller than the whole genome, but it contains many disease-causing variants because it includes protein-coding sequences. In immunobiology, that is where you often look for mutations that alter immune proteins.

Genetic variant

The result of exome sequencing is usually a list of genetic variants, and the real challenge is deciding which one matters. Some variants are harmless, while others disrupt immune function. In primary immunodeficiencies, you are often trying to match a variant to a symptom pattern and figure out whether it is likely pathogenic, likely benign, or uncertain.

Next-generation sequencing (NGS)

Whole exome sequencing usually depends on NGS because the method has to read millions of DNA fragments quickly. NGS is the technology that makes exome sequencing practical and cost-effective. In a lab or homework question, NGS is the platform, while whole exome sequencing is the targeted strategy for which regions get captured and analyzed.

common variable immunodeficiency (CVID)

CVID is one of the immune disorders where exome sequencing may be used when the diagnosis is not obvious from routine testing. Not every person with CVID has a single identifiable mutation, but sequencing can sometimes uncover inherited variants that help explain low antibody levels and recurrent infections. That makes it a good example of how genotype can inform an immune phenotype.

Is Whole exome sequencing on the IMMUNOBIOLOGY exam?

A quiz item or case study may give you recurrent infections, family history, and a genetic test result, then ask what whole exome sequencing is doing. Your job is to identify that it sequences protein-coding DNA and to connect that to primary immunodeficiencies, where a variant may explain a broken immune protein.

You might also see it in a short-answer prompt that asks why this method is preferred over broader testing in some cases. The answer is usually cost, speed, and focus on the regions most likely to contain disease-causing changes. If the case includes a negative standard workup, exome sequencing is the next logical step because it can uncover rare coding variants that routine tests miss.

When interpreting a result, look for the link between the mutated gene and the immune pathway it affects, not just the name of the disorder.

Whole exome sequencing vs Next-generation sequencing (NGS)

These are related, but they are not the same thing. NGS is the sequencing technology that reads lots of DNA fragments fast, while whole exome sequencing is a strategy that uses that technology to read only the protein-coding parts of the genome. If a question asks about the machine or platform, think NGS. If it asks what part of the genome is targeted, think whole exome sequencing.

Key things to remember about Whole exome sequencing

• Whole exome sequencing reads the protein-coding regions of DNA, which is where many disease-causing immune mutations are found.

• In Immunobiology, it is especially useful for primary immunodeficiencies because those disorders are often caused by inherited changes in immune genes.

• The method does not sequence all of the genome, so a negative result does not rule out every possible genetic cause.

• You use the results by linking a variant to the immune pathway it affects, such as B cells, phagocytes, or complement proteins.

• It is most helpful when routine testing does not explain recurrent infections, unusual infection patterns, or a strong family history.

Frequently asked questions about Whole exome sequencing

What is whole exome sequencing in Immunobiology?

It is a DNA sequencing method that focuses on the exome, the protein-coding part of the genome. In Immunobiology, it is used to look for variants that may explain inherited immune disorders, especially primary immunodeficiencies. The idea is to find a coding change that disrupts an immune protein.

Does whole exome sequencing sequence the whole genome?

No. It sequences only the exons, which are the parts of genes that code for proteins. That makes it narrower than whole genome sequencing, but faster and easier to interpret when you are looking for mutations that affect immune function.

Why is whole exome sequencing useful for primary immunodeficiencies?

Many primary immunodeficiencies come from inherited mutations in genes that control immune cells, antibodies, complement, or microbial killing. Whole exome sequencing can find rare variants that routine blood tests or single-gene tests might miss. It is especially useful when the diagnosis is unclear.

What is the difference between whole exome sequencing and NGS?

NGS is the sequencing technology, while whole exome sequencing is one way of using that technology. NGS does the fast reading of DNA fragments, and exome sequencing decides that only the coding regions will be captured and analyzed. They are connected, but they are not interchangeable terms.